USC Associate Professor of Ophthalmology Conducted Stem Cell Therapy Trial for AMD

USC Associate Professor of Ophthalmology Conducted Stem Cell Therapy Trial for AMD

In 2017, a patient named Anna Kuehl entered a clinical trial to test a stem cell remedy for macular degeneration. She had noticed a slow loss of vision in her left eye and as it gradually worsened, hope of avoiding loss of  precious sight to age-related macular degeneration (AMD) was dimming. In the study, Kuehl was treated by principal investigator and surgeon Amir H. Kashani, MD, at the University of Southern California. As reported recently the investigational procedure worked. Kuel’s vision has greatly improved to the point that she is back to normal activities that were not possible before.

Dr. Kashani implanted a stem cell patch—an ultrathin scaffold with cells that would replace the ones that had disappeared. Imagine if this can work for large number of people facing the scary prospect of AMD. Serving as principal investigator for this clinical trial, testing a novel stem cell therapy for severe vision loss from advanced dry age-related macular degeneration, the preliminary results of this study were published in Science Translation Medicine in April 2018.

Dr. Amir H. Kishani

Amir H. Kashani, MD, PhD attended Johns Hopkins School of Medicine where he obtained both ...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee